Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 3
2012 12
2013 12
2014 4
2015 9
2018 1
2019 2
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
KRAS-Mutant non-small cell lung cancer: From biology to therapy.
Ferrer I, Zugazagoitia J, Herbertz S, John W, Paz-Ares L, Schmid-Bindert G. Ferrer I, et al. Among authors: schmid bindert g. Lung Cancer. 2018 Oct;124:53-64. doi: 10.1016/j.lungcan.2018.07.013. Epub 2018 Jul 19. Lung Cancer. 2018. PMID: 30268480 Free article. Review.
Maintenance therapy in non-small-cell lung cancer.
Schmid-Bindert G. Schmid-Bindert G. Transl Lung Cancer Res. 2012 Jun;1(2):105-10. doi: 10.3978/j.issn.2218-6751.2011.10.02. Transl Lung Cancer Res. 2012. PMID: 25806166 Free PMC article. Review.
Pemetrexed for the treatment of non-small-cell lung cancer.
Manegold C, Schmid-Bindert G, Pilz LR. Manegold C, et al. Among authors: schmid bindert g. Expert Rev Anticancer Ther. 2009 Sep;9(9):1195-209. doi: 10.1586/era.09.97. Expert Rev Anticancer Ther. 2009. PMID: 19761423 Review.
Diffusion and perfusion MRI of the lung and mediastinum.
Henzler T, Schmid-Bindert G, Schoenberg SO, Fink C. Henzler T, et al. Among authors: schmid bindert g. Eur J Radiol. 2010 Dec;76(3):329-36. doi: 10.1016/j.ejrad.2010.05.005. Eur J Radiol. 2010. PMID: 20627435 Review.
A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer.
Metzenmacher M, Kopp HG, Griesinger F, Reinmuth N, Sebastian M, Serke M, Waller CF, Thomas M, Eggert J, Schmid-Bindert G, Hoiczyk M, Christoph DC, Kimmich M, Deuß B, Seifert S, Held S, Schuler M, Herold T, Breitenbuecher F, Eberhardt WEE. Metzenmacher M, et al. Among authors: schmid bindert g. Ther Adv Med Oncol. 2021 Mar 9;13:1758835921996506. doi: 10.1177/1758835921996506. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34104223 Free PMC article.
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer?
Pilz LR, Manegold C, Schmid-Bindert G. Pilz LR, et al. Among authors: schmid bindert g. Transl Lung Cancer Res. 2012 Mar;1(1):26-35. doi: 10.3978/j.issn.2218-6751.2011.12.08. Transl Lung Cancer Res. 2012. PMID: 25806152 Free PMC article. Review.
Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced Emphysema.
Slebos DJ, Cicenia J, Sciurba FC, Criner GJ, Hartman JE, Garner J, Deslée G, Delage A, Jantz M, Marquette CH, Strange C, Hatipoglu U, Mehta AC, LaPrad AS, Schmid-Bindert G, Herth FJF, Shah PL; RENEW Study Group. Slebos DJ, et al. Among authors: schmid bindert g. Chest. 2019 May;155(5):928-937. doi: 10.1016/j.chest.2019.02.012. Epub 2019 Feb 21. Chest. 2019. PMID: 30797746 Clinical Trial.
ROS1 fusions in Chinese patients with non-small-cell lung cancer.
Cai W, Li X, Su C, Fan L, Zheng L, Fei K, Zhou C, Manegold C, Schmid-Bindert G. Cai W, et al. Among authors: schmid bindert g. Ann Oncol. 2013 Jul;24(7):1822-1827. doi: 10.1093/annonc/mdt071. Epub 2013 Mar 20. Ann Oncol. 2013. PMID: 23514723 Free article.
45 results